Literature DB >> 12851303

PT-141: a melanocortin agonist for the treatment of sexual dysfunction.

P B Molinoff1, A M Shadiack, D Earle, L E Diamond, C Y Quon.   

Abstract

PT-141, a synthetic peptide analogue of alpha-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R, which are expressed primarily in the central nervous system. Administration of PT-141 to rats and nonhuman primates results in penile erections. Systemic administration of PT-141 to rats activates neurons in the hypothalamus as shown by an increase in c-Fos immunoreactivity. Neurons in the same region of the central nervous system take up pseudorabies virus injected into the corpus cavernosum of the rat penis. Administration of PT-141 to normal men and to patients with erectile dysfunction resulted in a rapid dose-dependent increase in erectile activity. The results suggest that PT-141 holds promise as a new treatment for sexual dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851303     DOI: 10.1111/j.1749-6632.2003.tb03167.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  20 in total

Review 1.  Melanocortinergic control of penile erection.

Authors:  H Wessells; J E Blevins; T W Vanderah
Journal:  Peptides       Date:  2005-10       Impact factor: 3.750

2.  Pain reduces sexual motivation in female but not male mice.

Authors:  Melissa A Farmer; Alison Leja; Emily Foxen-Craft; Lindsey Chan; Leigh C MacIntyre; Tina Niaki; Mengsha Chen; Josiane C S Mapplebeck; Vanessa Tabry; Lucas Topham; Melissa Sukosd; Yitzchak M Binik; James G Pfaus; Jeffrey S Mogil
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

3.  Discrete melanocortin-sensitive neuroanatomical pathway linking the ventral premmamillary nucleus to the paraventricular hypothalamus.

Authors:  L Gautron; R M Cravo; J K Elmquist; C F Elias
Journal:  Neuroscience       Date:  2013-02-26       Impact factor: 3.590

Review 4.  Sexual dysfunction in the older woman: an overview of the current understanding and management.

Authors:  Kathleen E Walsh; Jennifer R Berman
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist.

Authors:  James G Pfaus; Annette Shadiack; Tanya Van Soest; Maric Tse; Perry Molinoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

Review 6.  Late-stage clinical development in lower urogenital targets: sexual dysfunction.

Authors:  Usman Azam
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 7.  Animal models in urological disease and sexual dysfunction.

Authors:  Gordon McMurray; James H Casey; Alasdair M Naylor
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

8.  Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

Authors:  Thomas Durek; Philipp M Cromm; Andrew M White; Christina I Schroeder; Quentin Kaas; Joachim Weidmann; Abdullah Ahmad Fuaad; Olivier Cheneval; Peta J Harvey; Norelle L Daly; Yang Zhou; Anita Dellsén; Torben Österlund; Niklas Larsson; Laurent Knerr; Udo Bauer; Horst Kessler; Minying Cai; Victor J Hruby; Alleyn T Plowright; David J Craik
Journal:  J Med Chem       Date:  2018-04-11       Impact factor: 7.446

9.  Melanocortin receptors, melanotropic peptides and penile erection.

Authors:  Stephen H King; Alexander V Mayorov; Preeti Balse-Srinivasan; Victor J Hruby; Todd W Vanderah; Hunter Wessells
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

10.  Sexual Health in Women.

Authors:  Juliana M Kling; Stephanie S Faubion; Ekta Kapoor
Journal:  J Womens Health (Larchmt)       Date:  2020-09-07       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.